Compared to benign and borderline tumours, the extent of staining was, however, significantly increased in grade 3 ovarian tumours, with immunoreactivity for PPARγ being mostly present in the nuclear region (Figures 1 and 2). The gene discussed is PPARG; the disease is ovarian neoplasm.